New Zealand approves 'magic mushrooms' (psilocybin) for medicinal use, signaling a progressive step in mental health treatment and research.
New Zealand has recently given the green light to the use of 'magic mushrooms,' specifically psilocybin, for medicinal purposes. This decision marks a significant shift in the country's approach to mental health treatment, potentially offering new avenues for patients suffering from conditions like depression and anxiety.
The move reflects a growing global interest in the therapeutic potential of psychedelic substances when administered under strict medical supervision. New Zealand joins a small but increasing number of countries exploring the potential benefits of psilocybin-assisted therapy.